s-nitrosoglutathione has been researched along with Postoperative Complications in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de Belder, AJ; Langford, EJ; Marrinan, MT; Martin, JF; Parfitt, A | 1 |
Baskerville, PA; Fraser, SC; Markus, HS; Martin, JF; Molloy, J | 1 |
Hurst, T; Johnson, D; Mayers, I; Radomski, MW; Salas, E | 1 |
2 trial(s) available for s-nitrosoglutathione and Postoperative Complications
Article | Year |
---|---|
A study of platelet activation during human cardiopulmonary bypass and the effect of S-nitrosoglutathione.
Topics: Aged; Blood Platelets; Blood Pressure; Cardiopulmonary Bypass; Dose-Response Relationship, Drug; Female; Glutathione; Humans; Male; Middle Aged; Nitroso Compounds; P-Selectin; Pilot Projects; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIb-IX Complex; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Complications; S-Nitrosoglutathione; Time Factors | 1997 |
S-nitrosoglutathione reduces the rate of embolization in humans.
Topics: Aged; Anticoagulants; Aspirin; Carotid Stenosis; Endarterectomy, Carotid; Female; Glutathione; Heparin; Humans; Incidence; Intracranial Embolism and Thrombosis; Male; Middle Aged; Nitric Oxide Donors; Nitroso Compounds; Platelet Aggregation Inhibitors; Postoperative Complications; Premedication; Risk Factors; S-Nitrosoglutathione; Single-Blind Method; Ultrasonography, Doppler, Transcranial | 1998 |
1 other study(ies) available for s-nitrosoglutathione and Postoperative Complications
Article | Year |
---|---|
Increased nitric oxide synthase activity after canine cardiopulmonary bypass is suppressed by s-nitrosoglutathione.
Topics: Animals; Blood Gas Analysis; Cardiopulmonary Bypass; CD18 Antigens; Coronary Vessels; Disease Models, Animal; Dogs; Glutathione; Hemodynamics; Infusions, Intravenous; Intraoperative Period; Myocardium; Neutrophils; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitroso Compounds; Platelet Aggregation Inhibitors; Postoperative Complications; Random Allocation; S-Nitrosoglutathione | 1999 |